These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9891555)

  • 1. Prognostic factors in head and neck oncology: a critical appraisal for use in clinical practice.
    Chiesa F; Tradati N; Mauri S; Calabrese L; Grigolato R; Giugliano G; Zurrida S; Chiesa E; Squadrelli M; Viale G; Maiorano E
    Anticancer Res; 1998; 18(6B):4769-76. PubMed ID: 9891555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective reporting biases in cancer prognostic factor studies.
    Kyzas PA; Loizou KT; Ioannidis JP
    J Natl Cancer Inst; 2005 Jul; 97(14):1043-55. PubMed ID: 16030302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck.
    Argiris A; Li Y; Forastiere A
    Cancer; 2004 Nov; 101(10):2222-9. PubMed ID: 15452834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
    Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
    Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new prognostic indicator for head and neck cancer--p53 serum antibodies?
    Gottschlich S; Folz BJ; Goeroegh T; Lippert BM; Maass JD; Werner JA
    Anticancer Res; 1999; 19(4A):2703-5. PubMed ID: 10470224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of mitotic and apoptotic index and the DNA cytometry in head and neck cancer.
    Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
    Neoplasma; 2005; 52(3):199-207. PubMed ID: 15875080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular markers of head and neck cancer].
    Temam S; Janot F
    Rev Prat; 2006 Oct; 56(15):1658-61. PubMed ID: 17137250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential prognostic impact of comorbidity in head and neck cancer.
    Alho OP; Hannula K; Luokkala A; Teppo H; Koivunen P; Kantola S
    Head Neck; 2007 Oct; 29(10):913-8. PubMed ID: 17510970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for the malignant triton tumor of the head and neck.
    Terzic A; Bode B; Gratz KW; Stoeckli SJ
    Head Neck; 2009 May; 31(5):679-88. PubMed ID: 19283843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia in head and neck cancer: how much, how important?
    Janssen HL; Haustermans KM; Balm AJ; Begg AC
    Head Neck; 2005 Jul; 27(7):622-38. PubMed ID: 15952198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of telomerase expression in peripheral blood mononuclear cells of head and neck cancer patients.
    Lee BJ; Wang SG; Choi JS; Lee JC; Goh EK; Kim MG
    Am J Clin Oncol; 2006 Apr; 29(2):163-7. PubMed ID: 16601436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Good clinical practice in nutritional management of head and neck cancer patients].
    Meuric J; Garabige V; Blanc-Vincent MP; Lallemand Y; Bachmann P
    Bull Cancer; 1999 Oct; 86(10):843-54. PubMed ID: 10572235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival?
    Almadori G; Bussu F; Paludetti G
    Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):117-26. PubMed ID: 18327030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalizing cancer care: updates on head and neck cancer.
    de Souza JA; Cohen EE
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1219-22. PubMed ID: 19761425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
    Vordermark D; Brown JM
    Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of comorbidity in head and neck cancer.
    Piccirillo JF
    Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
    Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma.
    Hoebers FJ; Pameijer FA; de Bois J; Heemsbergen W; Balm AJ; Schornagel JH; Rasch CR
    Head Neck; 2008 Sep; 30(9):1216-23. PubMed ID: 18642295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy.
    Dietl B; Marienhagen J; Schäfer C; Kölbl O
    Clin Oncol (R Coll Radiol); 2007 May; 19(4):228-33. PubMed ID: 17433968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.